Botulinum-A toxin as a treatment of detrusor-sphincter dyssynergia: a prospective study in 24 spinal cord injury patients
- PMID: 8583552
- DOI: 10.1016/s0022-5347(01)66376-6
Botulinum-A toxin as a treatment of detrusor-sphincter dyssynergia: a prospective study in 24 spinal cord injury patients
Abstract
Purpose: The paralytic effect of botulinum-A toxin injections on the external urethral sphincter was investigated prospectively in patients with neurogenic voiding disorders.
Materials and methods: Transurethral versus transperineal botulinum-A toxin injections were performed in 24 spinal cord injury male patients with detrusor-sphincter dyssynergia and the respective efficacy was compared.
Results: In 21 of 24 patients detrusor-sphincter dyssynergia was significantly improved with a concomitant decrease in post-void residual volumes in most cases. Botulinum-A toxin effects lasted 3 to 9 months, making reinjections necessary.
Conclusions: Although costly, botulinum-A toxin injections, which aim at suppressing detrusor-sphincter dyssynergia but not bladder neck dyssynergia, appear to be a valid alternative for patients who do not desire surgery or are unable to perform self-catheterization.
Similar articles
-
Treatment of detrusor sphincter dyssynergia by transperineal injection of botulinum toxin.Arch Phys Med Rehabil. 1998 Jun;79(6):715-7. doi: 10.1016/s0003-9993(98)90050-8. Arch Phys Med Rehabil. 1998. PMID: 9630155 Clinical Trial.
-
Comparing a transrectal ultrasound-guided with a cystoscopy-guided botulinum toxin a injection in treating detrusor external sphincter dyssynergia in spinal cord injury.Am J Phys Med Rehabil. 2011 Sep;90(9):723-30. doi: 10.1097/PHM.0b013e31821a72a3. Am J Phys Med Rehabil. 2011. PMID: 21552106
-
Botulinum toxin as a new therapy option for voiding disorders: current state of the art.Eur Urol. 2003 Aug;44(2):165-74. doi: 10.1016/s0302-2838(03)00250-1. Eur Urol. 2003. PMID: 12875934 Review.
-
[Detrusor-sphincter dyssynergia and botulinum toxin].Ann Readapt Med Phys. 2003 Jul;46(6):319-25. doi: 10.1016/s0168-6054(03)00105-3. Ann Readapt Med Phys. 2003. PMID: 12928137 Review. French.
-
Botulinum toxin urethral sphincter injection to restore bladder emptying in men and women with voiding dysfunction.J Urol. 2001 Apr;165(4):1107-10. J Urol. 2001. PMID: 11257648
Cited by
-
Bladder management for adults with spinal cord injury: a clinical practice guideline for health-care providers.J Spinal Cord Med. 2006;29(5):527-73. J Spinal Cord Med. 2006. PMID: 17274492 Free PMC article. No abstract available.
-
An infantile case of Hinman syndrome with severe acute renal failure.Clin Exp Nephrol. 2008 Aug;12(4):309-311. doi: 10.1007/s10157-008-0048-3. Epub 2008 Apr 15. Clin Exp Nephrol. 2008. PMID: 18409063
-
Satisfaction with Urinary Incontinence Treatments in Patients with Chronic Spinal Cord Injury.J Clin Med. 2022 Oct 4;11(19):5864. doi: 10.3390/jcm11195864. J Clin Med. 2022. PMID: 36233731 Free PMC article.
-
[Botulinum toxin in urology. Indications and results].Urologe A. 2004 Nov;43(11):1410-5. doi: 10.1007/s00120-004-0652-0. Urologe A. 2004. PMID: 15309305 Review. German.
-
The Therapeutic Effects and Pathophysiology of Botulinum Toxin A on Voiding Dysfunction Due to Urethral Sphincter Dysfunction.Toxins (Basel). 2019 Dec 13;11(12):728. doi: 10.3390/toxins11120728. Toxins (Basel). 2019. PMID: 31847090 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical